Understanding abnormal mitochondrial function in pathophysiology has expanded beyond obvious disorders such as diabetes and obesity into those that include aging, cancer, cardiomyopathy, and ...

Cell viability assays such as Cell Titer Blue and Alamar Blue rely on the reducing property of viable cells and are commonly used as a screening method to determine the cytotoxic potential of ...

With the launch of the NULISAqpcr Custom Assay Development Kit, Alamar continues to demonstrate its commitment to driving innovation and supporting the scientific community with cutting-edge ...

Sapient will additionally be working closely with Alamar to offer NULISAseq assays under regulated guidance, including CAP/CLIA and GCLP. NULISA employs a sequential immunocomplex capture and ...

Under the terms of the partnership, Alamar Biosciences and ADx NeuroSciences will combine their respective expertise to provide tailored assay solutions to meet the specific needs of ...

ADx NeuroSciences and Alamar Biosciences have announced a partnership to develop customized biomarker assays for companies that advance novel therapeutics for a range of neurological conditions.

Under the terms of the partnership, Alamar Biosciences and ADx NeuroSciences will combine their respective expertise to provide tailored assay solutions to meet the specific needs of ...

Sapient will additionally be working closely with Alamar to offer NULISAseq assays under regulated guidance, including CAP/CLIA and GCLP. NULISA employs a sequential immunocomplex capture and release ...